Skip to main content
SpringerLink
Log in

Neoplasms Induced by Non-Cancer Therapies

  • Chapter
Etiology of Cancer in Man

Part of the book series: Cancer Growth and Progression ((CAGP,volume 6))

  • 56 Accesses

Abstract

The development of neoplasms in non-cancer patients due to therapy and analgesics abuse on the one hand, and the development of neoplasms in cancer patients due to therapy and treatment on the other, will be discussed in this chapter. The survival time of cancer patients has been increased substantially for certain types of neoplasms, especially by combination therapy, in particular, chemo- and radiotherapy. But this success became less pronounced by the appearance of secondary neoplasms in long-term survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antoniades J: Angiosarcoma of the skin and of the head and neck. Uncommon Malignant Tumors. Masson Publishing, 241–44, 1982

    Google Scholar 

  2. Ashley DJB: Evans’ Histological Appearance of Tumours. (Third edition) Vol. 1, pp. 83–84. Edinburgh, London & New York: Churchill Livingstone, 1978

    Google Scholar 

  3. Batzinger RP, Ou SY, Bueding E: Tert-butyl-hydroxyanisole and antimicrobial agents decrease levels of mutagenic metabolites. Fed Proc 37(3):596, 1978

    Google Scholar 

  4. Batzinger RP, Ou SY, Bueding E: Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res 38(12):4478, 1978a

    PubMed  CAS  Google Scholar 

  5. Bengtsson U, et al.: Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2:145, 1968

    Article  PubMed  CAS  Google Scholar 

  6. Bengtsson U, Johansson S, Angervall L: Malignancies of the urinary tract and their relation to analgesic abuse. Kidnev Int 13:107, 1978

    Article  CAS  Google Scholar 

  7. Bengtsson U: Glomerulonephritis and organic solvents. Lancet 2(8454):566, 1985

    Article  PubMed  CAS  Google Scholar 

  8. Bufano G, Biasini A, Magri S, Pecchini F: Italian studies on neoplasms in the course of dialysis. Minerva Nefrol 30(2 suppl):9, 1983

    PubMed  CAS  Google Scholar 

  9. Cha YN, Heine H, Ansher S, Bueding E: Comparative effects of dietary anticarcinogens and other inducers on hepatic enzymes of mice. Fed Proc 40(3):744, 1980

    Google Scholar 

  10. Davin T, Cosio F, Kjellstrand C: Association of cancer with primary renal disease and/or uremia. Cancer and the Kidney: Lea and Febiger, 857–68, 1982

    Google Scholar 

  11. Dunhill MS, Millard R, Oliver D: Acquired cystic disease of the kidneys: A hazard of long-term intermittent maintenance hemodialysis. J Clin Pathol 30:868, 1977

    Article  Google Scholar 

  12. Dunsford HA, Keysser CH, Dolan PM, Seed JL, Bueding E: Carcinogenicity of the antischistosomal nitrofuran trans-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole. JNCI 73(1):151, 1984

    PubMed  CAS  Google Scholar 

  13. Dunsford HA, Dolan PM, Seed JL, Bueding E: Effects of multiple putative anticarcinogens on the carcinogenicity of trans-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole. JNCI 73(1):161, 1984a

    PubMed  CAS  Google Scholar 

  14. Eby CS, Brennan MJ, Fine G: Lymphangiosarcoma: A lethal complication of chronic lymphedema. Report of two cases and review of the literature. Arch Surg 94:223, 1967

    PubMed  CAS  Google Scholar 

  15. Eisenbrand G: Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities. IARC Sci Publ 57:695, 1984

    PubMed  CAS  Google Scholar 

  16. Ellison GW, Myers LW: Immunosuppressive drugs in multiple sclerosis: Pro and con. Neurology (Minneap) 30(7, part 2):28, 1980

    CAS  Google Scholar 

  17. Feliner S, Tuttle E: The clinical syndrome of analgesic abuse. Arch Intern Med 124:379, 1969

    Article  Google Scholar 

  18. Gonwa T, et al.: Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93:249, 1980

    PubMed  CAS  Google Scholar 

  19. Herr HW, Engen DE, Hostetter J: Malignancy in uremia: Dialysis versus transplantation. J Urol 121:584, 1979

    PubMed  CAS  Google Scholar 

  20. Herrman JB: Lymphoangiosarcoma of the chronically edematous extremity. Surg Gynecol Obstet 121:1107, 1965

    Google Scholar 

  21. Hoybye G, Nealson OE: Renal pelvic carcinoma in phenacetin abusers. Scand J Urol Nephrol 5:292, 1971

    Google Scholar 

  22. Hughson ND, Hennigar GR, McManus FA: Atypical cysts, acquired renal cystic disease and renal cell tumors in end-stage dialysis kidneys. Lab Invest 51:475, 1980

    Google Scholar 

  23. Hultengren N, Lagergren C, Ljungqvist A: Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand 130:314, 1965

    PubMed  CAS  Google Scholar 

  24. Ishikawa I, et al.: Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients. Clin Nephrol 14, 1980

    Google Scholar 

  25. Kalimo H, Frey H, Raine CS, et al: Late-onset malignant astrocytoma in a case of multiple sclerosis. Acta Neuropathol (Berl) 46(3):231, 1979

    Article  CAS  Google Scholar 

  26. Kinlen LJ, et al.: Cancer in patients receiving dialysis. Brit Med J 2:1401, 1980

    Article  Google Scholar 

  27. Kornhuber HH, Mauch E, Petru E, et al.: Risk of cancer in cyclophosphamide therapy of multiple sclerosis (letter). Dtsch Med Wochenschr 112(13):530, 1987

    PubMed  CAS  Google Scholar 

  28. Kuno K, Fukami A, Kasumi F, Hori M, Watanabe S: Lymphedema and function of the arm after mastectomy for breast cancer. Gan No Rinsho 30(6 suppl):670, 1984

    PubMed  CAS  Google Scholar 

  29. Lown JW, Koganty RR, Chauhan SM: Characterization of alkyldinitrogen species implicated in the carcinogenic, mutagenic and anticancer activities of N-nitroso compounds. IARC Sci Publ 57:689, 1984

    PubMed  CAS  Google Scholar 

  30. MacKenzie DH: Lymphoangiosarcoma arising in chronic congenital and idiopathic lymphoedema. J Clin Pathol 24:524, 1971

    Article  PubMed  CAS  Google Scholar 

  31. Martin W: Do we get too much iron? Med Hypotheses 14(2):131, 1984

    Article  PubMed  CAS  Google Scholar 

  32. Matas AJ, et al.: Increased incidence of malignancy in uremic patients and its significance to transplantation. Transplant Proc 9:1137, 1977

    Google Scholar 

  33. Miach PJ, Dawborn JK, Xipell J: Neoplasia in patients with chronic renal failure on dialysis. Clin Nephrol 5:101, 1976

    PubMed  CAS  Google Scholar 

  34. Mougeot-Martin M, Krulik M, Harousseau JL, et al.: Acute leukemia following immunosuppressive therapy for disseminated sclerosis and for Behcet’s syndrome. Ann Med Interne (Paris) 129(3):175, 1978

    CAS  Google Scholar 

  35. Nielsen OH, Jacobsen O, Pedersen ER, et al.: Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol 29(1): 13, 1985

    Article  Google Scholar 

  36. Pecchini F, Vagelli G: Clinical aspects of tumors in the course of dialysis. Minerva Nefrol 30(2 suppl):41, 1983

    PubMed  CAS  Google Scholar 

  37. Prunner SP, et al.: Tumoren der ableitenden Harnwege und Analgetika-Abusus. Schweiz Med Wochenschr 108:1013, 1978

    Google Scholar 

  38. Richie JP, Garnick MB: Primary renal and ureteral cancer. In: Cancer and the Kidney, edited by Rieselbach RE, Garnick MB, Philadelphia: Lea & Febiger, pp. 662–706, 1982

    Google Scholar 

  39. Slifkin RF, et al.: Malignancy in end-stage renal disease. Trans Am Soc Artif Intern Organs 23:34, 1977

    PubMed  CAS  Google Scholar 

  40. Sodomann CP, Gropp C: How high is the risk of malignant tumors following immunosuppressive treatment? Internist (Berlin) 20(12):571, 1979

    CAS  Google Scholar 

  41. Soffer T, Chan WC, Brynes RK, Vogler WR, O’Neal S: Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancer. Cancer 54(11):2356, 1984

    Article  PubMed  CAS  Google Scholar 

  42. Spuhler O, Zollinger HU: Die chronische interstitielle Nephritis. Z Klin Med 151:1, 1953

    PubMed  CAS  Google Scholar 

  43. Stewart FW, Treves N: Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica. Cancer 1:64, 1948

    Article  PubMed  CAS  Google Scholar 

  44. Sutherland GA, Glass G, Gabriel R: Increased incidence of malignancy in chronic renal failure. Nephron 18:182, 1977

    Article  PubMed  CAS  Google Scholar 

  45. Talalay P, Batzinger RP, Benson AM, Bueding E, Cha Y: Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv Enzyme Regul 17:23, 1979

    Article  CAS  Google Scholar 

  46. Taylor AT, Wade AE: Chemical carcinogenicity and the antineoplastic agents. Am J Hosp Pharm 41(9): 1844, 1984

    PubMed  CAS  Google Scholar 

  47. Tchernia G, Mielot F, Subtil E, et al.: Acute myeloblastic leukemia after immunodepressive therapy for primary non-malignant disease. Blood Cells 2(1-2):67, 1976

    Google Scholar 

  48. Terreira (personal communication).

    Google Scholar 

  49. Tsuda H, Sarma DS, Rajalakshmi S, Zubroff J, Farber E, Batzinger RP, Cha YN, Bueding E: Induction of hepatic neoplastic lesions in mice with a single dose of hycanthone methanesulfonate after partial hepatectomy. Cancer Res 39(11):4491, 1979

    PubMed  CAS  Google Scholar 

  50. Thysell H, Bygren P, Bengtsson U, Lindholm T, Norlin M, Brun C, Larsen S, Jorgensen F: Improved outcome in rapidly progressive glomerulonephritis by plasma exchange treatment. Int J Artif Organs 6 suppl 1:11, 1983

    PubMed  Google Scholar 

  51. Ulbright TM, Santa Cruz DJ: Kaposi’s sarcoma: Relationship with hematologic, lymphoid, and thymic neoplasia. Cancer 47(5):963, 1981

    Article  PubMed  CAS  Google Scholar 

  52. Wang SY, Hahn BS, Batzinger RP, Bueding E: Mutagenic activities of hydroperoxythymine derivatives, products of radiation and oxidation reactions. Biochem Biophvs Res Commun 89(1):259, 1979

    Article  CAS  Google Scholar 

  53. Wing AJ, Jacobs C, Seiwood NH: Malignant diseases in dialysis and transplant patients. Minerva Nefrol 30(2 suppl):3, 1983

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. E. Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institutes of Child Health & Human Development, National Institutes of Health, Bethesda, Md., USA

    Arthur S. Levine

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Dordrecht

About this chapter

Cite this chapter

Kaiser, H.E. (1989). Neoplasms Induced by Non-Cancer Therapies. In: Levine, A.S. (eds) Etiology of Cancer in Man. Cancer Growth and Progression, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2532-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2532-8_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7644-9

  • Online ISBN: 978-94-009-2532-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation